Q&A: Why people at increased risk of thrombosis are safe to get the AstraZeneca vaccine
Rare blood clots linked to the vaccine 'are a different entity'
Six Australians have now developed thrombosis with thrombocytopenia syndrome (TTS), the rare disorder associated with AstraZeneca’s COVID-19 vaccine.
Incorrect perceptions about risk are fuelling hesitancy among patients who have an increased risk or personal history of clots.
